Navigation Links
d’Oliveira & Associates Releases New Webpage on Pradaxa Lawsuits
Date:3/6/2013

(PRWEB) March 06, 2013

Manufactured by Boehringer Ingelheim, Pradaxa is an anticoagulant drug that is used to treat a variety of blood and heart conditions*. In October 2010, the Food and Drug Administration (FDA) approved Pradaxa for sale on the market*. As reported by the NY Times, Pradaxa was marketed as a superior drug choice to Warfarin, but medical studies suggest that Pradaxa may be more dangerous than Warfarin*. The NY Times article goes on to explain that excessive bleeding from Warfarin can treated with Vitamin K, but the anticoagulant drug Pradaxa has no such treatment to counteract excessive bleeding*. The FDA lists the Pradaxa side effects that may include nosebleeds, discolored urine and stool, unusual hemorrhaging, headaches, and swelling**. More serious medical conditions linked to Pradaxa may include heart attack, stroke, and even death**. The USA Today reports the FDA has received over 3,781 reports of unfavorable Pradaxa side effects, which include about alleged 2,400 hemorrhages, 291 cases of acute renal failure, 640 strokes, and 542 deaths***.

Sources:
*http://www.nytimes.com/2012/11/03/business/a-rising-anti-stroke-drug-is-tied-to-risk-of-bleeding-deaths.html?_r=0
**http://www.fda.gov/Drugs/DrugSafety/ucm326580.htm
***usatoday30.usatoday.com/news/health/story/2012-08-19/pradaxa-blood-thinner-lawsuit/57134628/1

Pradaxa lawsuits have alleged the drug contained inadequate warnings, which did not fairly apprise patients of the serious health risks associated with the drug*. Pradaxa’s manufacturer, Boehringer Ingelheim, also faces wrongful death claims and on August 8, 2012, Pradaxa lawsuits were consolidated in the United States District Court for the Southern District of Illinois (MDL-2385)*. Over 150 cases with 165 plaintiffs have been included in this Pradaxa Multidistrict Litigation*. Recently, the judge overseeing this litigation issued an order requiring Boehringer Ingelheim to produce “Paper and Pradaxa-Specific Electronic Custodial files**.”

Sources:
*http://www.ilsd.uscourts.gov/mdl/mdl2385.aspx
**http://www.ilsd.uscourts.gov/Documents/mdl2385/cmo17.pdf

If you believe that you or one of your loved ones has been injured by Pradaxa, you may want to speak with a personal injury lawyer regarding a dangerous drug claim. A Pradaxa lawyer familiar with new developments in the investigation of the drug Pradaxa may be able to help you make important personal and legal decisions. d'Oliveira & Associates, P.C. is working with some of the leading Pradaxa lawyers and dangerous drug attorneys in the country who are handling these cases.

Please contact the law offices of d'Oliveira & Associates, P.C at 1-800-992-6878 or fill out a contact form for a free legal consultation.

Read the full story at http://www.prweb.com/releases/2013/3/prweb10418353.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. d’Oliveira & Associates Issues Webpage With Current Information On Stryker Hip Implant Lawsuits
2. d’Oliveira & Associates Releases Webpage With Current Information on Fresenius Lawsuits
3. d’Oliveira & Associates Releases Mirena IUD Infographic Describing Bayer’s Deceptive Mirena Simple Style Campaign
4. d’Oliveira & Associates Issues Webpage With Current Information On Mirena IUD Lawsuits
5. Research shows efficacy of treatment model developed at Women & Infants
6. Soy-based S-equol supplement reduces hot flash frequency, muscle & joint pain in US women
7. Vendors in Nevada, Michigan, & Illinois to be Featured on the PartyPOP.com Online Network
8. Beef & Pork Wholesaling in the US Industry Market Research Report Now Available from IBISWorld
9. The Tennessee Car Accident Lawyers at Michael D. Ponce & Associates Alert Public of CDC Survey Revealing Majority of High School Seniors Admitting to Texting Behind Wheel
10. Alex Galindo, Attorney and Partner at Curd, Galindo & Smith, LLP, Court Wins Against the County of Riverside's Motion to Dismiss Medical Malpractice Case
11. Play & Park Structures Included in New Play for All Abilities Playground
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... CA (PRWEB) , ... October 12, 2017 , ... ... Cheng, are now treating sleep apnea using cutting-edge Oventus O2Vent technology. ... a serious sleep disorder characterized by frequent cessation in breathing. Oral appliances can ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( ... today the introduction of an innovative new design of the shoulder pad. The ... get maximum comfort while controlling your pain while using cold therapy. By utilizing ice ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... that we intend to develop to enable prevention of a major side effect ... hearing loss, especially in pediatric patients. For cisplatin, hearing loss is FDA listed ...
(Date:10/12/2017)... ... 12, 2017 , ... Leading pediatric oncology experts at Children’s National Health ... Congress of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired ... Cancer and Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., Chief ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... nation's first interactive health literacy software tool, and the Cancer Patient Education Network ... cancer patient education, today announce a new strategic alliance. , As CPEN’s ...
Breaking Medicine News(10 mins):
(Date:10/10/2017)...  NDS received FDA 510(k) clearance in May 2017 for its ... specifically designed for endoscopy environments. An innovative secondary monitor solution, ZeroWire ... to support the improvement of patient outcomes, procedural efficiency, and the ... ... ...
(Date:10/4/2017)...  South Korean-based healthcare product Development Company I.M. Lab ... Kickstarter. The device will educate the user about ,proper, ... efficiency compared to the dated and pricey CPR training ... of the compression for a more informed CPR training. ... raise $5,000. cprCUBE ...
(Date:10/2/2017)... Lilly and Company (NYSE: LLY ) will ... 2017 on Tuesday, October 24, 2017. Lilly will also ... investment community and media to further detail the company,s ... at 9 a.m. Eastern time. Investors, media and the ... conference call through a link that will be posted ...
Breaking Medicine Technology: